- Home
- POOL vs RVNC Comparison
POOL vs RVNC Comparison
Compare POOL & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POOL
- RVNC
- Stock Information
- Founded
- POOL 1993
- RVNC 1999
- Country
- POOL United States
- RVNC United States
- Employees
- POOL N/A
- RVNC N/A
- Industry
- POOL Industrial Specialties
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- POOL Consumer Discretionary
- RVNC Health Care
- Exchange
- POOL Nasdaq
- RVNC Nasdaq
- Market Cap
- POOL 13.8B
- RVNC 320.5M
- IPO Year
- POOL 1995
- RVNC 2014
- Fundamental
- Price
- POOL $349.04
- RVNC $3.09
- Analyst Decision
- POOL Hold
- RVNC Hold
- Analyst Count
- POOL 8
- RVNC 9
- Target Price
- POOL $369.25
- RVNC $8.45
- AVG Volume (30 Days)
- POOL 339.0K
- RVNC 3.6M
- Earning Date
- POOL 02-20-2025
- RVNC 11-07-2024
- Dividend Yield
- POOL 1.38%
- RVNC N/A
- EPS Growth
- POOL N/A
- RVNC N/A
- EPS
- POOL 11.61
- RVNC N/A
- Revenue
- POOL $5,326,524,000.00
- RVNC $256,945,000.00
- Revenue This Year
- POOL N/A
- RVNC $11.28
- Revenue Next Year
- POOL $3.90
- RVNC $27.21
- P/E Ratio
- POOL $30.06
- RVNC N/A
- Revenue Growth
- POOL N/A
- RVNC 25.82
- 52 Week Low
- POOL $293.51
- RVNC $2.30
- 52 Week High
- POOL $422.73
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- POOL 38.15
- RVNC 33.47
- Support Level
- POOL $340.00
- RVNC $3.06
- Resistance Level
- POOL $380.82
- RVNC $3.09
- Average True Range (ATR)
- POOL 8.16
- RVNC 0.11
- MACD
- POOL -3.71
- RVNC 0.02
- Stochastic Oscillator
- POOL 22.15
- RVNC 6.90
About POOL Pool Corporation
Pool Corp distributes swimming pool supplies and related products. It sells national-brand and private-label products to approximately 120000 customers. The products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.